KEGG: pst:PSPTO_1434
STRING: 223283.PSPTO_1434
IspG (also known as GcpE) is a crucial enzyme in the methylerythritol phosphate (MEP) pathway that catalyzes the penultimate step in isoprenoid precursor biosynthesis. Specifically, ispG converts 2-C-methyl-D-erythritol-2,4-cyclodiphosphate (MEcPP) into (E)-4-hydroxy-3-methylbut-2-enyl pyrophosphate (HMBPP). This conversion involves the reduction and opening of the cyclic diphosphate intermediate . The MEP pathway is essential for isoprenoid biosynthesis in bacteria and plastids of plants, making ispG a critical enzyme for the survival of organisms like Pseudomonas syringae.
IspG contains a [4Fe-4S] cluster at its active site, which is essential for its catalytic activity. The enzyme requires this iron-sulfur cluster for electron transfer during the reduction reaction. The active site structure creates a specific binding pocket for MEcPP, allowing for the coordination of the substrate with the iron-sulfur cluster. In its active form, the enzyme contains a [4Fe-4S] cluster, not the [3Fe-4S] cluster sometimes reported in earlier literature . This structural arrangement is crucial for the enzyme's ability to perform the reductive transformation of MEcPP to HMBPP through a series of electron transfer steps.
For recombinant expression of ispG from P. syringae, the following methodology has proven effective:
Bacterial expression system: E. coli BL21(DE3) strains with pET-based vectors under T7 promoter control.
Expression conditions: Induction with 0.1-0.5 mM IPTG at lower temperatures (16-20°C) for 16-20 hours to enhance protein folding and [4Fe-4S] cluster incorporation.
Media supplementation: Addition of iron (FeCl₃, 50-100 μM) and cysteine (0.5-1 mM) to enhance iron-sulfur cluster formation.
Anaerobic conditions: Expression under microaerobic or anaerobic conditions to prevent oxidative damage to the [4Fe-4S] cluster.
Due to the oxygen sensitivity of the [4Fe-4S] cluster, all purification steps should be performed under anaerobic conditions using glove boxes or Schlenk techniques to maintain enzyme activity .
The purification of recombinant ispG requires specific techniques to preserve the oxygen-sensitive [4Fe-4S] cluster:
Anaerobic purification: All steps must be conducted in an anaerobic chamber or using Schlenk techniques.
Buffer composition: Standard buffers include 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5-10% glycerol, and 1-5 mM DTT or 2-mercaptoethanol as reducing agents.
Purification steps:
Immobilized metal affinity chromatography (IMAC) using His-tagged protein
Size exclusion chromatography to remove aggregates
Ion exchange chromatography for higher purity
[4Fe-4S] cluster reconstitution: If the cluster is damaged during purification, in vitro reconstitution can be performed using:
| Component | Concentration | Purpose |
|---|---|---|
| FeCl₃ | 0.5-1 mM | Iron source |
| Na₂S | 0.5-1 mM | Sulfur source |
| DTT | 5-10 mM | Reducing agent |
| Protein | 50-100 μM | Enzyme |
The reconstitution mixture should be incubated anaerobically at 4°C for 2-4 hours, followed by desalting to remove excess reagents .
The catalytic activity of ispG requires an electron transfer system to supply the electrons needed for the reduction reaction. For bacterial ispG enzymes, including those from P. syringae, the following electron transfer systems can be used:
Physiological electron donors:
NADPH/flavodoxin/flavodoxin reductase system (bacterial)
Ferredoxin/ferredoxin reductase system (some bacteria and plants)
Artificial electron donors for in vitro assays:
5-deazaflavin semiquinone radical (photoactivated deazaflavin)
Sodium dithionite
Methyl viologen radical
To reconstitute these systems in vitro, researchers should include:
| Component | Concentration | Source |
|---|---|---|
| NADPH | 1-2 mM | Commercial |
| Flavodoxin | 10-20 μM | Recombinant |
| Flavodoxin reductase | 1-2 μM | Recombinant |
| ispG | 1-5 μM | Recombinant |
| Substrate (MEcPP) | 0.1-1 mM | Synthetic or enzymatically prepared |
The reaction mixture should be incubated anaerobically at 30°C, and product formation can be monitored by HPLC or LC-MS analysis .
Multiple catalytic mechanisms have been proposed for ispG, with three predominant theories:
Radical-based mechanism: Involves formation of an allylic radical intermediate through homolytic cleavage of the C-O bond.
Bioorganometallic mechanism: Involves direct coordination of the substrate to the [4Fe-4S] cluster, forming metallacycle intermediates.
Allyl cation mechanism: Proposes that the [4Fe-4S] cluster acts as a Lewis acid to facilitate C-O bond cleavage and formation of an allyl cation intermediate.
To experimentally distinguish between these mechanisms, the following approaches can be employed:
EPR spectroscopy: To detect and characterize radical intermediates
Mössbauer spectroscopy: To analyze changes in the [4Fe-4S] cluster during catalysis
ENDOR spectroscopy: To study the interaction between the substrate and the [4Fe-4S] cluster
Substrate analogs: Synthesize analogs with specific isotopic labels or chemical modifications to trap intermediates
Site-directed mutagenesis: Modify key active site residues to probe their roles in the proposed mechanisms
Computational studies: Perform density functional theory calculations to evaluate energetic barriers for different mechanistic pathways
These complementary approaches can provide evidence for or against specific mechanistic proposals .
Recombineering offers powerful approaches for genetic manipulation of ispG in P. syringae. Specifically, the RecTE system from P. syringae can be utilized for precise genomic modifications:
Gene disruption methodology:
Express the RecTEPsy proteins in P. syringae pv. tomato DC3000
Design PCR products with 80-83 bp homology flanking regions targeting the ispG gene
Transform the PCR product into cells expressing RecTEPsy
Select recombinants using appropriate antibiotic markers
Verify gene disruption by PCR and sequencing
Point mutation introduction:
Design ssDNA oligonucleotides (70-100 nucleotides) containing the desired mutation flanked by homologous sequences
Transform the oligonucleotide into cells expressing RecTPsy
Implement a selection strategy if possible
Screen colonies by PCR and sequence verification
The recombineering efficiency for dsDNA with the RecTEPsy system is approximately 11-45 recombinants per 10⁸ viable cells, significantly higher than controls without RecTEPsy expression .
Mutations or deletions in the ispG gene in P. syringae can have profound effects on cellular physiology due to the essential nature of the MEP pathway. These effects can be observed and measured through:
Growth phenotypes:
Complete deletion is likely lethal unless complemented or in mevalonate-supplemented media
Partial activity mutations may show temperature-sensitive growth
Quantitative growth curve analysis to measure growth rates
Metabolite profiling:
LC-MS or GC-MS analysis of MEP pathway intermediates, particularly accumulation of MEcPP
Quantification of downstream isoprenoids using targeted metabolomics
Measurement of IPP and DMAPP levels in conditional mutants
Virulence assessment:
Plant infection assays to evaluate bacterial fitness and virulence
Measurement of symptom development in host plants
Bacterial population dynamics in planta
Volatile organic compound (VOC) analysis:
These multifaceted approaches can provide comprehensive insights into the functional consequences of ispG perturbation in P. syringae.
Comparative analysis reveals important differences between ispG from P. syringae and homologs from other organisms:
Structural conservation and differences:
Core catalytic domain with [4Fe-4S] cluster binding motif is highly conserved across bacteria and plants
Three cysteine residues that coordinate the [4Fe-4S] cluster are strictly conserved
Species-specific variations exist in substrate binding pocket residues
Functional differences:
Bacterial ispG enzymes (including P. syringae) utilize NADPH/flavodoxin/flavodoxin reductase as electron donors
Plant ispG (such as from Arabidopsis thaliana) cannot use bacterial electron transfer systems and instead require plant-specific ferredoxin systems
The plant enzyme shows activity only in the presence of 5-deazaflavin semiquinone radical under experimental conditions
Evolutionary implications:
Despite the MEP pathway being present in both bacteria and plant plastids, the electron transfer requirements have diverged
This divergence suggests evolutionary adaptation to different cellular environments and redox systems
These differences have important implications for developing selective inhibitors and understanding the evolution of the MEP pathway across different kingdoms of life.
Structural modeling of P. syringae ispG can provide valuable insights into substrate specificity and potential inhibitor binding sites:
Homology modeling approach:
Generate models based on crystal structures of ispG homologs (e.g., from E. coli or T. thermophilus)
Refine models through molecular dynamics simulations
Validate models using experimental data on known mutants
Active site analysis:
Identify residues involved in substrate binding and catalysis
Analyze the [4Fe-4S] cluster environment
Compare with known structures to identify unique features of P. syringae ispG
Virtual screening methodology:
Perform docking simulations with potential inhibitors
Use scoring functions to rank ligand binding affinities
Verify predictions through experimental enzyme inhibition assays
Substrate specificity prediction:
Dock natural substrate (MEcPP) and substrate analogs
Analyze binding energy and catalytic site interactions
Identify residues that contribute to substrate recognition
Experimental validation:
Site-directed mutagenesis of predicted key residues
Enzyme kinetics with substrate analogs
Inhibition studies with compounds identified through virtual screening
This integrated computational and experimental approach can guide the development of selective inhibitors targeting P. syringae ispG while minimizing effects on plant homologs .
The activity of ispG in P. syringae plays multiple roles in plant-pathogen interactions through its contribution to isoprenoid biosynthesis:
Bacterial survival and fitness:
The MEP pathway provides essential isoprenoids for bacterial membrane and cellular functions
IspG activity is required for bacterial growth and multiplication in planta
Virulence factor production:
Isoprenoid-derived molecules may contribute to bacterial virulence
The MEP pathway products serve as precursors for secondary metabolites involved in pathogenesis
Modulation of plant defense responses:
MEP pathway products can potentially interfere with plant signaling
Bacterial isoprenoids may mimic or antagonize plant defense molecules
Impact on plant volatile signaling:
Understanding these interactions can provide insights into both bacterial pathogenesis mechanisms and potential targets for disease control strategies.
Several methodological approaches can be employed to investigate how ispG inhibition affects P. syringae pathogenicity:
Chemical biology approaches:
Use fosmidomycin or other MEP pathway inhibitors at sub-lethal concentrations
Apply controlled gene expression systems (e.g., inducible promoters) to modulate ispG expression levels
Utilize conditional mutants (temperature-sensitive or nutrient-dependent)
Plant infection assays:
Measure bacterial growth curves in planta under ispG inhibition
Assess disease symptom development (chlorosis, necrosis)
Quantify bacterial population dynamics using fluorescent or luminescent reporter strains
Defense response monitoring:
Analyze plant defense gene expression (e.g., PR1) upon infection with ispG-inhibited bacteria
Measure salicylic acid (SA) and pipecolic acid (Pip) accumulation in infected tissues
Monitor systemic acquired resistance (SAR) development
Metabolite profiling:
Analyze changes in bacterial and plant isoprenoid profiles
Measure volatile organic compound (VOC) emissions, particularly monoterpenes
Quantify MEP pathway intermediates and end products
Imaging techniques:
Use confocal microscopy with fluorescently labeled bacteria to track infection progress
Apply MALDI-imaging to map metabolite distributions during infection
These techniques provide complementary information about the role of ispG and the MEP pathway in P. syringae pathogenicity and plant-pathogen interactions .
Engineering ispG for enhanced isoprenoid production requires addressing several key aspects of enzyme function:
Protein engineering strategies:
Directed evolution to improve catalytic efficiency
Site-directed mutagenesis of residues involved in:
Substrate binding (to improve affinity)
Product release (often rate-limiting)
[4Fe-4S] cluster stability (to enhance oxygen tolerance)
Domain swapping with homologs from thermophilic organisms to improve stability
Redox partner engineering:
Co-expression of optimal electron transfer proteins (flavodoxin and flavodoxin reductase)
Engineering of electron transfer interface between ispG and redox partners
Balancing NADPH supply through cofactor regeneration systems
Expression optimization:
Codon optimization for target host
Implementation of appropriate promoters and ribosome binding sites
Balancing expression with other MEP pathway enzymes to prevent bottlenecks
Subcellular compartmentalization or membrane association to improve pathway flux
Oxygen sensitivity mitigation:
Development of oxygen-tolerant variants through protein engineering
Implementation of oxygen scavenging systems
Creation of microaerobic cultivation strategies
These approaches can be combined in a systematic metabolic engineering framework to enhance the MEP pathway flux and increase isoprenoid production .
A comprehensive analytical toolkit is essential for accurate assessment of ispG activity and product formation:
Spectrophotometric assays:
Monitoring NADPH oxidation at 340 nm in coupled assays
UV-Vis spectroscopy to track [4Fe-4S] cluster state changes
Chromatographic techniques:
HPLC with UV detection for HMBPP quantification
LC-MS/MS for sensitive and specific quantification of MEcPP and HMBPP
Ion-pairing reversed-phase chromatography for separation of phosphorylated intermediates
Enzymatic coupled assays:
Using IspH to convert HMBPP to IPP/DMAPP
Coupling with prenyltransferases that utilize IPP/DMAPP
Metabolite extraction protocols:
Quenching with cold methanol (-40°C)
Extraction with acidified acetonitrile/water mixtures
Solid-phase extraction for sample cleanup
Advanced MS techniques:
High-resolution LC-MS for untargeted metabolomics
Multiple reaction monitoring (MRM) for targeted quantification
Isotope dilution methods using labeled standards
Real-time monitoring:
Implementation of biosensors responsive to MEP pathway intermediates
Transcriptional reporters linked to pathway activity
GC-MS analysis of headspace samples for volatile isoprenoid products
| Analysis Target | Recommended Method | Sensitivity Range | Key Advantages |
|---|---|---|---|
| HMBPP (in vitro) | LC-MS/MS with MRM | 0.1-100 μM | High specificity, quantitative |
| MEcPP consumption | Ion-pairing HPLC | 1-100 μM | Direct substrate monitoring |
| Pathway flux | ¹³C-labeled precursor tracing | N/A | Dynamic pathway analysis |
| End products | GC-MS or LC-MS | Compound-dependent | Comprehensive isoprenoid profiling |
These analytical approaches enable rigorous characterization of ispG function and its impact on isoprenoid biosynthesis .
The most promising strategies for elucidating structure-function relationships in P. syringae ispG include:
Advanced structural biology approaches:
Cryo-electron microscopy to capture different catalytic states
Neutron diffraction to identify hydrogen positions in the active site
Time-resolved X-ray crystallography to capture reaction intermediates
Integrated spectroscopic techniques:
Combined EPR, ENDOR, and Mössbauer spectroscopy to characterize [4Fe-4S] cluster states
Resonance Raman spectroscopy to analyze substrate-cluster interactions
NMR studies with isotopically labeled substrates to track reaction progress
Synthetic biology platforms:
Development of minimal synthetic systems reconstituting ispG and its redox partners
Cell-free expression systems for rapid mutant screening
Reconstitution in nanodiscs or liposomes to mimic membrane environments
Computational approaches:
Quantum mechanics/molecular mechanics (QM/MM) simulations of catalytic mechanisms
Machine learning to identify patterns in sequence-function relationships
Network analysis to understand interactions with other cellular components
These multidisciplinary approaches will provide deeper insights into the fundamental properties and biological roles of P. syringae ispG, potentially leading to new applications in biocatalysis and antimicrobial development .
Research on P. syringae ispG has significant potential to inform the development of novel antimicrobial strategies through several avenues:
Targeted inhibitor development:
Design of transition state analogs based on mechanistic understanding
Identification of allosteric inhibitors through structure-based drug design
Development of prodrugs activated by P. syringae-specific enzymes
Selective targeting advantages:
Bacterial ispG differs from mammalian isoprenoid biosynthesis (which uses the mevalonate pathway)
Structural differences between bacterial and plant ispG can be exploited for specificity
The essential nature of the MEP pathway makes it an attractive antibiotic target
Combination therapy strategies:
Synergistic effects when combining ispG inhibitors with other MEP pathway inhibitors
Potential for enhancing efficacy of existing antibiotics through metabolic weakening
Development of multi-target approaches addressing both virulence and bacterial survival
Innovative delivery mechanisms:
Nanoparticle-based delivery of ispG inhibitors
Phage-based delivery systems for targeted antimicrobial action
Plant-expressed RNAi constructs targeting bacterial ispG expression
The unique position of ispG in bacterial metabolism and its divergence from host pathways make it a promising target for next-generation antimicrobial development, particularly for agricultural applications against P. syringae and related plant pathogens .